ClinicalTrials.gov
ClinicalTrials.gov Menu

Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00142480
Recruitment Status : Completed
First Posted : September 2, 2005
Last Update Posted : April 25, 2018
Sponsor:
Collaborators:
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Genentech, Inc.
Sanofi-Synthelabo
Hoffmann-La Roche
Information provided by (Responsible Party):
Andrew X. Zhu, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2007
  Actual Study Completion Date : April 2011